WHO lot testing programme for malaria rapid diagnostic tests (RDTs), 2007–2022

Overview

The WHO lot testing programme for malaria rapid diagnostic tests (RDTs) is an independent quality control system designed to evaluate lot to lot variation in performance of malaria RDTs. The purpose of this programme is to ensure that only the highest quality malaria RDT lots are procured and used in endemic countries. Currently, the Research Institute for Tropical Medicine (RITM) (Philippines) serves as the only WHO-sponsored and monitored laboratory evaluating RDT lots according to WHO procedures, using well-characterized and standardized parasite samples for quality control of malaria RDTs. 

This document provides an overview of the results for the period 2007-2022.